“…The birthweights of our series are compared with a control group of 23 children without retrolental fibroplasia, at present in the Fountain Hospital, who weighed less than 5 lb (2,270 g.) at birth. Zacharias, Reynolds, Chisholm, and King (1954) have shown that, in America between 1934 and 1952, there was a three-fold increase in the number of children weighing 4 lb (1,800 g.) or less who survived, and it seems reasonable therefore to postulate that a proportion of these had some degree of neural damage or defect associated with prematurity, and that the association of retrolental fibroplasia in some of them might be purely coincidental. Douglas (1956), in a detailed study, has been following up all the premature children born in the first week of March, 1946. Out of 676 premature babies, he found that six were educationally subnormal, whereas there were only two so affected in his carefully matched group of controls.…”
“…The birthweights of our series are compared with a control group of 23 children without retrolental fibroplasia, at present in the Fountain Hospital, who weighed less than 5 lb (2,270 g.) at birth. Zacharias, Reynolds, Chisholm, and King (1954) have shown that, in America between 1934 and 1952, there was a three-fold increase in the number of children weighing 4 lb (1,800 g.) or less who survived, and it seems reasonable therefore to postulate that a proportion of these had some degree of neural damage or defect associated with prematurity, and that the association of retrolental fibroplasia in some of them might be purely coincidental. Douglas (1956), in a detailed study, has been following up all the premature children born in the first week of March, 1946. Out of 676 premature babies, he found that six were educationally subnormal, whereas there were only two so affected in his carefully matched group of controls.…”
“…Several workers produced or evaluated evidence pertaining to the rate of oxygen administration in the etiology of retrolental fibroplasia (1,14,15,16,17,80,89,93,113,118,122,123,124,125,155,162,177,179,187,189,219,252,259,260,342).…”
Section: Retrolental Fibroplasia (Retinopathy Of Prematurity)mentioning
“…Caregivers in the neonatal intensive care unit (NICU) must continuously maintain a fragile balance between administering too much and too little supplemental oxygen to preterm infants to prevent morbidity and mortality. Several neonatal morbidities have been linked to a disturbance in this balance, intermittent hypoxia being associated with retinopathy of prematurity (ROP),1 neurodevelopmental impairment and death,2 and hyperoxia with ROP 3…”
ObjectiveTo compare the effect of two different automated oxygen control devices on time preterm infants spent in different oxygen saturation (SpO2) ranges during their entire stay in the neonatal intensive care unit (NICU).DesignRetrospective cohort study of prospectively collected data.SettingTertiary level neonatal unit in the Netherlands.PatientsPreterm infants (OxyGenie 75 infants, CLiO2111 infants) born at 24–29 weeks’ gestation receiving at least 72 hours of respiratory support between October 2015 and November 2020.InterventionsInspired oxygen concentration was titrated by the OxyGenie controller (SLE6000 ventilator) between February 2019 and November 2020 and the CLiO2controller (AVEA ventilator) between October 2015 and December 2018 as standard of care.Main outcome measuresTime spent within SpO2target range (TR, 91–95% for either epoch) and other SpO2ranges.ResultsTime spent within the SpO2TR when receiving supplemental oxygen was higher during OxyGenie control (median 71.5 [IQR 64.6–77.0]% vs 51.3 [47.3–58.5]%, p<0.001). Infants under OxyGenie control spent less time in hypoxic and hyperoxic ranges (SpO2<80%: 0.7 [0.4–1.4]% vs 1.2 [0.7–2.3]%, p<0.001; SpO2>98%: 1.0 [0.5–2.4]% vs 4.0 [2.0–7.9]%, p<0.001). Both groups received a similar FiO2(29.5 [28.0–33.2]% vs 29.6 [27.7–32.1]%, p=not significant).ConclusionsOxygen saturation targeting was significantly different in the OxyGenie epoch in preterm infants, with less time in hypoxic and hyperoxic SpO2ranges during their stay in the NICU.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.